Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Domino′s Pizza® Announces First Quarter 2026 Financial Results (PR Newswire) +++ DOMINOS PIZZA Aktie -3,50%

WUXI APPTEC Aktie

 >WUXI APPTEC Aktienkurs 
13.84 EUR    +3.1%    (TradegateBSX)
Ask: 14.042 EUR / 362 Stück
Bid: 13.802 EUR / 369 Stück
Tagesumsatz: 1193 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
WUXI APPTEC Aktie über LYNX handeln
>WUXI APPTEC Performance
1 Woche: +0,6%
1 Monat: +9,5%
3 Monate: +6,9%
6 Monate: +8,6%
1 Jahr: +108,8%
laufendes Jahr: +25,8%
>WUXI APPTEC Aktie
Name:  WUXI APPTEC H 02359 YC1
Land:  China
Sektor:  Gesundheit
ISIN/ Wkn:  CNE100003F19 / A2PAJG
Symbol/ Ticker:  WX8 (Frankfurt)
Kürzel:  FRA:WX8, ETR:WX8, WX8:GR
Index:  -
Webseite:  https://www.wuxiapptec.co..
Profil:  WuXi AppTec Co., Ltd. is a leading global pharmaceutical and biotechnology company that provides comprehensive research and development services. Its primary function is to facilitate drug discovery and development processes for pharmaceutical compan..
>Volltext..
Marktkapitalisierung:  36908.21 Mio. EUR
Unternehmenswert:  33024.67 Mio. EUR
Umsatz:  5210.42 Mio. EUR
EBITDA:  -
Nettogewinn:  2285.82 Mio. EUR
Gewinn je Aktie:  0.8 EUR
Schulden:  1027.82 Mio. EUR
Liquide Mittel:  3597.14 Mio. EUR
Operativer Cashflow:  2093.33 Mio. EUR
Bargeldquote:  2.13
Umsatzwachstum:  1.76%
Gewinnwachstum:  81.03%
Dividende je Aktie:  0.04 EUR
Dividendenrendite:  1.17%
Dividendenschätzung:  1.86%
Div. Historie:  08.09.25 - 0.042478535€
17.06.24 - 0.120048285€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  WUXI APPTEC
Letzte Datenerhebung:  27.04.26
>WUXI APPTEC Kennzahlen
Aktien/ Unternehmen:
Aktien: 463.51 Mio. St.
Frei handelbar: 93.67%
Leerverk. Aktien: -
Rückkaufquote: -0.87%
Mitarbeiter: 33834
Umsatz/Mitarb.: 0.15 Mio. EUR
Analysten:
Analystenrating: Strong buy
Kursziel: 21.29%
Bewertung:
KGV: 17.13
KGV lG: 18.17
KUV: 7.66
KBV: 4.07
PEG-Ratio: 0.16
EV/EBITDA: -
Rentabilität:
Bruttomarge: 51.91%
Gewinnmarge: 40.46%
Operative Marge: 36.01%
Managementeffizenz:
Gesamtkaprendite: 19.2%
Eigenkaprendite: 25.44%
>WUXI APPTEC Peer Group
Gesundheit, Zell- & Gentherapie/ Gentechnik/ Erbkrankheiten
 
27.04.26 - 11:57
WuXi AppTec gives Q1 numbers (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
27.04.26 - 11:06
WuXi AppTec Delivers Strong Revenue and Profit Growth in Q1 2026 (PR Newswire)
 
Total Revenue Reached RMB 12.44 Billion; Revenue from Continuing Operations Up 39.4% YoY Adjusted Non-IFRS Net Profit Up 71.7% YoY to RMB 4.60 Billion Backlog for Continuing Operations Up 23.6% YoY to RMB 59.77 Billion SHANGHAI, April 27, 2026 /PRNewswire/ -- WuXi AppTec (stock code:......
27.04.26 - 10:45
Blue Chip WUXI APPTEC 1Q26 Net Profit Up 26.7% YoY to RMB4.65B (AAStocks)
 
WUXI APPTEC (02359.HK) announced its results for the first quarter ended end-March 2026. Under the China Accounting Standards for Business Enterprises, revenue reached RMB12.436 billion, up 28.8% YoY. Net profit was approximately RMB4.652 billion, up 26.7% YoY; EPS was RMB1.59.The company explained that the increase in revenue a......
27.04.26 - 09:15
G Sachs: Mainland CDMO Sector Remains Resilient, Favors Wuxi AppTec , Asymchem and Others (AAStocks)
 
G Sachs published a research report on the mainland pharmaceutical sector, stating that the results of CDMO companies reflect that the sectors cycle remains resilient. Earnings visibility is increasingly dependent on exposure to late-stage and commercialization projects rather than early-stage financing conditions. Artificial i......
23.04.26 - 05:00
Research: CLSA Raises WUXI APPTEC TP to HKD149.3, Maintains Outperform (AAStocks)
 
Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...
20.04.26 - 07:30
Research: Citi Lifts WUXI APPTEC TP to $158.5 w/ Rating Buy (AAStocks)
 
Citi Research issued a research report lifting its target prices for WUXI APPTEC (02359.HK)'s H-/ A-shares from $156/ RMB138 to $158.5/ RMB140, with ratings at Buy, reflecting a 2% upward revision to revenue and EPS forecasts, based on Citi Research's optimistic outlook for Eli Lilly and Company (LLY.US)'s tirzepatid......
17.04.26 - 09:45
Shanghai and Shenzhen Markets: ChiNext Index Rises 1.4% to Fresh Near 11-Year High; CATL Down Over 2%, WuXi AppTec Slumps Nearly 6% (AAStocks)
 
The RMB central parity rate against the USD was set at 6.8622, down 6 pips MoM. The People's Bank of China conducted RMB500 million of seven-day reverse repo operations in the open market today (17th), with the operation rate unchanged at 1.4%. With RMB2 billion of reverse repos maturing today, there was a net daily withdrawal o......
02.04.26 - 06:30
G Sachs Adds Yum China ADR , WuXi AppTec and Haitian Flavouring to Asia-Pacific Conviction List Buy (AAStocks)
 
Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...
26.03.26 - 06:00
Research: JPM Raises WuXi AppTec TP to HKD150, Maintains 'Overweight' Rating (AAStocks)
 
JPMorgan released a research report stating that WuXi AppTec (02359.HK) management has set this year's revenue guidance between RMB513 billion and RMB530 billion, which includes foreign exchange factors. The management revealed that the potential growth rate calculated at a constant exchange rate could reach approximately 22% to......
24.03.26 - 06:30
WuXi AppTec shares rally as FY profit more than doubles (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
24.03.26 - 05:30
Midday Takeaway: HSI Up 447 pts; HSTI Up 67 pts; WUXI APPTEC Up over 8%; EB ENVIRONMENT, QINGSONG HEALTH Hit New Highs (AAStocks)
 
At midday close, HSI rose 447 pts or 1.8% to 24,829. HSTI rose 67 pts or 1.4% to 4,779. HSCEI gained 118 pts or 1.4% to 8,426.Active Heavyweights:MEITUAN (03690.HK) closed at $78.45, up 2.5%PING AN (02318.HK) closed at $58.75, up 2.2%TENCENT (00700.HK) closed at $507.5, up 1.8%BABA (09988.HK) closed at $121.6, up 1.6%XIAOMI (018......
24.03.26 - 03:00
WUXI APPTEC Opens Up 4% as 2025 NP Rises 1.05x, Final DPS Increases; Interim DPS Proposed for This Yr (AAStocks)
 
WUXI APPTEC (02359.HK) opened up 4% this morning (24th) at HKD106.8. It last traded at HKD108.6, up 5.74%, with a volume of 529,400 shares, involving HKD56.9711 million.After the market closed yesterday (23rd), WUXI APPTEC announced its annual results for the year ended December 2025. Its turnover grew by 15.8% YoY to RMB45.456 ......
23.03.26 - 11:06
WuXi AppTec Beat Full-Year Guidance and Achieved Record Performance in 2025 (PR Newswire)
 
2025 Total Revenue Reached RMB 45.46 Billion; Revenue from Continuing Operations Up 21.4% YoY Adjusted Non-IFRS Net Profit Up 41.3% YoY to RMB 14.96 Billion Backlog for Continuing Operations Up 28.8% YoY to RMB 58.00 billion SHANGHAI, March 23, 2026 /PRNewswire/ -- WuXi AppTec (stock......
23.03.26 - 10:15
Results: WUXI APPTEC Annual NP RMB19.195B, Up 105.2%; Final DPS Hikes to RMB1.57927 (AAStocks)
 
WUXI APPTEC (02359.HK) announced its full-year results for the year ended December 31, 2025. Revenue reached RMB45.456 billion, up 15.8% YoY. It recorded a net profit of RMB19.195 billion, up 105.2% YoY, with an EPS of RMB6.72. A final DPS of RMB1.57927 was declared, compared to RMB0.98169 in the same period last year.~AAStocks ......
27.02.26 - 06:15
Research: M Stanley Lists Thematic Focus List- High Conviction Opportunities in APAC (Table) (AAStocks)
 
Stock:TSMC (2330.TW)TENCENT (00700.HK)Samsung Electronics (005930.KS)CATL (300750.SZ)Reliance Industries (RELI.NS)Sony (6758.JP)AIA (01299.HK)Delta Electronics (2308.TW)NAURA (002371.SZ)Fujitsu (6702.JP)WUXI APPTEC (02359.HK)Fujikura (5803.JP)Goodman (GMG.AX)Hanwha Aerospace(012450.KS)INOVANCE TECH (300124.SZ)PING AN (02318.HK)G......
27.02.26 - 05:30
Research: CLSA Favors CDMOs for Earnings Visibility, Top Picks WUXI APPTEC/ WUXI BIO/ PHARMARON (AAStocks)
 
As AI technology continues to develop, investors are shifting their focus from "AI enabling industries" to "AI disintermediating middlemen", CLSA said in a research report. For CRO/ CDMO, AI is expected to have a clearer net positive for integrated CRDMO platforms. In contrast, the internal adoption of AI by ......
23.02.26 - 14:21
XFRA: MWBMU: ENDE DER HANDELSUNTERBRECHUNG FUER DIV. WERTPAPIERE - TEIL 2 (XETRA)
 
CNE100003F19 CNE100003FC4 CNE100003FF7 CNE100003FL5 CNE100003K53 CNE100003KK7 CNE100003PH2 CNE1000040M1 CNE100004JD2 CNE1000055Z1 CNE1000057K9 CNE100005RV4 CNE100006624 CNE1000069Z2 CNE100006JG0 CNE100006M66 CNE100006N08 CNE100006NF4 CNE100006NX7 CNE100006QK7 CNE100006S86 CNE100006T02 CNE100006V73 CNE100006Z61 CNE100006Z79 CNE1000070H8 CNE1000070L0 CNE1000076P8 CNE100007C18 CNE100007CV2 CNE100007DG1 CNE100007DW8 CNE100007F07 CNE100007F72 CNE100007F98 CY0103562118 DE000A0N3UD5 DE000A351SC5 DK0060817898 DK0061026119 DK0061078425 DK0061123312 DK0061407699 DK0061408580 DK0061411964 DK0061417144 DK0061536828 DK0061675006 DK0061805660 DK0063855085 HK0000120151 HK0000504214 HK0000527306 HK0000544194 HK0000709128 HK0000735800 HK0000827664 HK0000981941 HK0014000126 HK0345001611 HK0521001989 HK0560006634 HK0836012952 ID1000058407 ID1000074008 ID1000094204 ID1000097207 ID1000100209 ID1000110000 ID1000118300 ID1000125107 ID1000125909 ID1000165004...
23.02.26 - 09:51
XFRA: MWBMU - HANDELSUNTERBRECHUNG - TEIL 7 (XETRA)
 
US88706T1088 KYG8918W1069 VGG878801114 CA87357T3001 FI4000176557 BMG3775G1539 CNE1000004H7 CNE1000001C4 HK0000981941 CNE100007F72 JP3535800001 US8740361063 KYG910191363 HK0000827664 BRUSIMACNOR3 ID1000191109 SE0017769136 SGXE24586385 GB00BN4M3M55 ES0105670006 GB00BMBVXB73 ES0105650008 ES0105650073 KYG0958D1060 CA88089G2027 CNE100005RV4 GB00BNBQZW49 AU000000EGH7 US84612H1068 US33744V1035 CA00686A1084 ID1000058407 AU0000312480 SE0017616006 SE0010102095 US69355M1071 US96145W1036 US2316472073 CNE100007DW8 ES0105618005 KYG2050P1028 AU0000150351 SE0017082514 GB00BLR8T846 CA59100N1042 KYG2117N1088 AU000000LIN6 HK0345001611 GB0001482891 AU000000DCC9 SG1J24887775 CNE100006JG0 JP3960000002 CA58046P1080 CH0210362643 IT0005678104 ZAE000167391 PLRNDCB00011 CA37150L1031 CA3638821015 ID1000100209 US9426221019 BMG8403G1033 CA60256C2076 BMG2118X1056 PLBRTZM00010 PLYLWHT00012 CA18914M2076 US9396531017 CNE100003F19 SE0017486103 KYG5244R1083 US98419J3059...
20.02.26 - 04:00
Research: M Stanley Hikes TP of WUXI APPTEC (02359.HK) to HKD143.5, Rating Overweight (AAStocks)
 
Given the preliminary 2025 results disclosed by WUXI APPTEC (02359.HK), Morgan Stanley raised its earnings forecast for 2026-30 by 0-3% on increased gross margins, thus increasing the target price from HKD143 to HKD143.5, the broker said in its research report. The broker assigned an Overweight rating to WUXI APPTEC, predicting ......
16.02.26 - 06:15
Research: Macquarie Recommends Accumulating WUXI APPTEC, Expects No Impact from US 1260H List (AAStocks)
 
Earlier, the US recently unveiled the latest Section 1260H list of Chinese military companies, which was later abruptly withdrawn. This list included WUXI APPTEC (02359.HK), Macquarie's research report said. The broker stated that the 1260H list is not an investment ban; companies on the list are primarily prohibited from co......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Das Gesetz ist nichts anderes als ein richtiges, von dem Wesen der Götter hergeleitetes Gebot der Vernunft, welches das, was ehrbar ist, gebietet, und das, was entgegensteht, verwehrt. - Marcus Tullius Cicero
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!